Stock analysts at UBS Group initiated coverage on shares of Ardent Health (NYSE:ARDT - Get Free Report) in a research report issued to clients and investors on Wednesday, Marketbeat reports. The brokerage set a "buy" rating and a $17.00 price target on the stock. UBS Group's price target suggests a potential upside of 25.93% from the company's current price.
A number of other analysts have also commented on the company. Royal Bank Of Canada reissued an "outperform" rating and set a $21.00 price objective on shares of Ardent Health in a report on Thursday, May 15th. Bank of America lowered Ardent Health from a "neutral" rating to an "underperform" rating and reduced their price objective for the company from $15.50 to $14.60 in a report on Wednesday, July 16th. Wall Street Zen upgraded Ardent Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 9th. JPMorgan Chase & Co. lowered their price objective on Ardent Health from $18.00 to $15.00 and set a "neutral" rating on the stock in a research report on Monday, August 11th. Finally, KeyCorp reduced their target price on Ardent Health from $24.00 to $20.00 and set an "overweight" rating on the stock in a research note on Thursday, August 7th. Nine research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $19.33.
Check Out Our Latest Stock Analysis on Ardent Health
Ardent Health Stock Performance
Shares of ARDT opened at $13.50 on Wednesday. The firm has a market cap of $1.93 billion, a price-to-earnings ratio of 7.46, a PEG ratio of 5.97 and a beta of 0.30. Ardent Health has a 52-week low of $10.10 and a 52-week high of $20.72. The company has a debt-to-equity ratio of 0.66, a quick ratio of 2.00 and a current ratio of 2.13. The business's fifty day moving average is $12.33 and its 200-day moving average is $13.16.
Ardent Health (NYSE:ARDT - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.52 EPS for the quarter, topping the consensus estimate of $0.30 by $0.22. The firm had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.54 billion. Ardent Health had a return on equity of 16.66% and a net margin of 4.11%. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. Equities analysts anticipate that Ardent Health will post 1.23 EPS for the current fiscal year.
Institutional Investors Weigh In On Ardent Health
Hedge funds have recently modified their holdings of the business. Point72 Asia Singapore Pte. Ltd. bought a new position in Ardent Health in the 4th quarter worth $27,000. CWM LLC lifted its holdings in shares of Ardent Health by 990.6% in the 2nd quarter. CWM LLC now owns 2,203 shares of the company's stock valued at $30,000 after acquiring an additional 2,001 shares during the last quarter. Morse Asset Management Inc bought a new position in shares of Ardent Health in the 1st quarter valued at about $36,000. Deutsche Bank AG lifted its holdings in shares of Ardent Health by 1,251.9% in the 4th quarter. Deutsche Bank AG now owns 2,866 shares of the company's stock valued at $49,000 after acquiring an additional 2,654 shares during the last quarter. Finally, Quarry LP lifted its holdings in shares of Ardent Health by 1,519.4% in the 1st quarter. Quarry LP now owns 5,020 shares of the company's stock valued at $69,000 after acquiring an additional 4,710 shares during the last quarter.
About Ardent Health
(
Get Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ardent Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.
While Ardent Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.